143 related articles for article (PubMed ID: 12640983)
81. Trials are halted on gene therapy: child in experiment falls ill--new setback for research.
Stolberg SG
N Y Times Web; 2002 Oct; ():A1, A25. PubMed ID: 12474837
[No Abstract] [Full Text] [Related]
82. Clinical gene-marking of mesenchymal cells.
Horwitz EM; Kasow KA; Hofmann TJ
Cytotherapy; 2003; 5(3):194-6. PubMed ID: 12850786
[No Abstract] [Full Text] [Related]
83. Basic research tries to decrease the risks of translational medicine.
Cavazzana-Calvo M
Gene Ther; 2009 Mar; 16(3):309-10. PubMed ID: 19279646
[No Abstract] [Full Text] [Related]
84. [Gene therapy].
Demonté D; Van Lint C; Burny A
Rev Med Brux; 2002 Sep; 23(4):A331-4. PubMed ID: 12422456
[TBL] [Abstract][Full Text] [Related]
85. [Successful gene therapy of children with severe immunodeficiency. Research breakthrough hopefully for the treatment of other diseases, too].
Fasth A; Mellgren K; Karlsson S; Richter J
Lakartidningen; 2002 Jul; 99(28-29):3010-2. PubMed ID: 12170507
[No Abstract] [Full Text] [Related]
86. Body, cure thyself.
Wheelwright J
Discover; 2002 Mar; 23(3):62-9. PubMed ID: 12426699
[No Abstract] [Full Text] [Related]
87. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
Dropulic B
Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
[TBL] [Abstract][Full Text] [Related]
88. Gene therapy--where do we go?
Etzioni A
Isr Med Assoc J; 2003 Dec; 5(12):883-4. PubMed ID: 14689758
[No Abstract] [Full Text] [Related]
89. Gene therapy saves immune deficient babies in France.
Dobson R
BMJ; 2000 May; 320(7244):1225. PubMed ID: 10797020
[No Abstract] [Full Text] [Related]
90. Gene therapy: how close to clinical reality?
Agarwal SS
Natl Med J India; 2009; 22(1):1-4. PubMed ID: 19761149
[No Abstract] [Full Text] [Related]
91. Safeguards for gene therapy trials.
FDA Consum; 2003; 37(3):5. PubMed ID: 12793378
[No Abstract] [Full Text] [Related]
92. The Journal of Gene Medicine 2002 Young Investigator Award. European Society of Gene Therapy.
Woods NB
J Gene Med; 2003 Jan; 5(1):85-6. PubMed ID: 12516055
[No Abstract] [Full Text] [Related]
93. SCID trials to remain on the 'bubble'.
Mandavilli A
Nat Med; 2003 Mar; 9(3):251. PubMed ID: 12612562
[No Abstract] [Full Text] [Related]
94. Gene therapy of severe combined immunodeficiency. Interview with Alain Fischer.
Fischer A
J Gene Med; 2000; 2(4):297-300. PubMed ID: 10953921
[No Abstract] [Full Text] [Related]
95. Retroviral gene therapy--where now?
Günzburg WH
Trends Mol Med; 2003 Jul; 9(7):277-8. PubMed ID: 12900211
[No Abstract] [Full Text] [Related]
96. FDA halts gene therapy trials after leukaemia case in France.
Marwick C
BMJ; 2003 Jan; 326(7382):181. PubMed ID: 12543825
[No Abstract] [Full Text] [Related]
97. What sort of people do we want? The ethics of changing people through genetic engineering.
Reiss MJ
Notre Dame J Law Ethics Public Policy; 1999; 13(1):63-92. PubMed ID: 11838490
[No Abstract] [Full Text] [Related]
98. A voluntary moratorium?
Verma IM
Mol Ther; 2003 Feb; 7(2):141. PubMed ID: 12638540
[No Abstract] [Full Text] [Related]
99. Gene therapy of metabolic diseases.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Inherit Metab Dis; 2006; 29(2-3):409-12. PubMed ID: 16763910
[TBL] [Abstract][Full Text] [Related]
100. Rules on gene therapy are tightened after leukaemia alert.
Hargreaves S
BMJ; 2002 Oct; 325(7368):791. PubMed ID: 12376429
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
